Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
BMJ Open|February 20, 2016
Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort studyGisèle Pickering, Gaëtan Gavazzi, Jacques Gaillat, et al.BMC Infectious Diseases|August 20, 2015
Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in FranceCecile Blein, Gaetan Gavazzi, Marc Paccalin, et al.Current Alzheimer Research|April 18, 2017
Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients Control CCL4 and CXCL10 Levels in a Human Blood Brain Barrier ModelJulie Verite, Thierry Janet, Adrien Julian, et al.Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|October 8, 2024
[Clostridioides difficile infections: Update and therapeutic guidelines]Gilles Berrut, Claire Roubaud Baudron, Marc Paccalin, et al.Soins. Gerontologie|November 7, 2024
[Collaboration between oncogeriatrics and DAC: the experience of Ucog Poitou-Charentes]Caroline Tran, Simon Valero, Mélanie BouissetJournal of Neuroinflammation|December 17, 2013
Involvement of interleukin-1β in the autophagic process of microglia: relevance to Alzheimer's diseaseArnaud François, Faraj Terro, Thierry Janet, et al.Molecular and Cellular Neurosciences|December 11, 2017
Trans ε-viniferin is an amyloid-β disaggregating and anti-inflammatory drug in a mouse primary cellular model of Alzheimer's diseaseElodie Vion, Guylène Page, Eric Bourdeaud, et al.Gerontology|February 21, 2008
Usefulness of the short IQCODE for predicting postoperative delirium in elderly patients undergoing hip and knee replacement surgeryMathieu Priner, Maud Jourdain, Gauthier Bouche, et al.Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|November 20, 2018
Prognosis of geriatric patients with severe kidney diseaseSophie Samso, Marc-Arthur Loko, Amélie Jamet, et al.Journal of Cellular and Molecular Medicine|February 13, 2009
PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patientsMilena Damjanac, Guylène Page, Stéphanie Ragot, et al.Pageof 10